Skip to content
★ Sign in to follow
C바

CJ 바이오사이언스 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by CJ제일제당, was filed 19 Dec 2024.

CJ 바이오사이언스: what insiders have been doing

CJ 바이오사이언스 is a Health Care company. Its directors and officers file their transactions with DART (FSS). No insider at CJ 바이오사이언스 has published a filing in the past twelve months. The most recent one dates from 19 December 2024.

In the same sector, recent insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
22
Thresholds
n/a
Buy Volume
n/a
22 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Cj제일제당2 buys
Last declaration on 19 December 2024
Declarations22 total
  • ▲
    Executives
    0DART
    3,952,960 sharesKRXDART:20241219000383
    Canonical exit: 18 Mar 2025 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20241219000375
    Canonical exit: 18 Mar 2025 (T+90)
  • ▲
    Executives
    0DART
    3,952,960 sharesKRXDART:20230906000306
    Canonical exit: 1 Dec 2023 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20230823000025
    Canonical exit: 17 Nov 2023 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20230822000276
    Canonical exit: 17 Nov 2023 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20230822000255
    Canonical exit: 17 Nov 2023 (T+90)
  • ▲
    Executives
    0DART
    3,952,960 sharesKRXDART:20230822000244
    Canonical exit: 17 Nov 2023 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20230807000376
    Canonical exit: 30 Oct 2023 (T+90)
  • ▲
    Executives
    0DART
    3,952,960 sharesKRXDART:20230807000357
    Canonical exit: 30 Oct 2023 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20230725000041
    Canonical exit: 17 Oct 2023 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20230725000296
    Canonical exit: 17 Oct 2023 (T+90)
  • ▲
    -Executives
    0DART
    ShareKRXDART:20230725000477
    Canonical exit: 17 Oct 2023 (T+90)
  • ▲
    Executives(filed)
    0DART
    3,952,960 sharesKRXDART:20211102000195
    Canonical exit: 31 Jan 2022 (T+90)
  • ▲
    -Executives(filed)
    0DART
    ShareKRXDART:20211102000201
    Canonical exit: 31 Jan 2022 (T+90)
  • ▲
    -Executives(filed)
    0DART
    ShareKRXDART:20211102000191
    Canonical exit: 31 Jan 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    3,952,960 sharesKRXDART:20211102000186
    Canonical exit: 31 Jan 2022 (T+90)
  • ▲
    -Executives(filed)
    0DART
    ShareKRXDART:20211102000113
    Canonical exit: 31 Jan 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    3,952,960 sharesKRXDART:20211102000109
    Canonical exit: 31 Jan 2022 (T+90)
  • ▲
    Executives(filed)
    0DART
    3,952,960 sharesKRXDART:20210728000077
    Canonical exit: 26 Oct 2021 (T+90)
  • ▲
    Executives(filed)
    0DART
    3,952,960 sharesKRXDART:20210728000092
    Canonical exit: 26 Oct 2021 (T+90)
  • ▲
    Executives(filed)
    0DART
    3,952,960 sharesKRXDART:20210728000080
    Canonical exit: 26 Oct 2021 (T+90)
  • ▲
    -Executives(filed)
    0DART
    ShareKRXDART:20210430000321
    Canonical exit: 29 Jul 2021 (T+90)

22 of 22 declarations

About CJ 바이오사이언스

CJ BioScience is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of biopharmaceutical products and innovative health solutions.